U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder - 03/10/2020 - 03/10/2020
  1. News & Events for Human Drugs

Meeting

Event Title
Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder
March 10, 2020

Postponed

Date:
March 10, 2020
Time:
12:30 PM - 5:00 PM ET


UPDATED INFORMATION (as of 3/9/2020): Due to extenuating circumstances, the Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder scheduled for March 10, 2020 is being postponed until further notice.

On March 10, 2020, FDA is hosting a public meeting on Patient-Focused Drug Development for Stimulant Use Disorder. This meeting will provide FDA the opportunity to obtain input from individuals who are struggling or have struggled with the use of cocaine, crystal meth, or misuse of prescription stimulants such as Adderall or Ritalin. Family members, advocates, caregivers and other stakeholders are encouraged to participate and share their views on the condition. In particular, FDA is interested in hearing perspectives on the:

  • Health effects and daily impacts of their condition
  • Impact (if any) of opioid and polysubstance use on their condition
  • Treatment goals
  • Decision factors considered when seeking out or selecting a treatment

This website will be updated as meeting materials are developed.

You may attend in-person or virtually. This event is FREE.

Date:

March 10, 2020

Time:

12:30 PM – 5:00 PM ET

Location:
Silver Spring Civic Building
1 Veterans Plaza, Silver Spring, MD 20910

Registration:

To register for this meeting visit:

https://stimulantusedisorder-pfdd.eventbrite.com

We encourage registration for this event in order to receive updates and reminders about the meeting. If you do not wish to register, anonymous walk-ins will be permitted.

Webcast Link:

http://fda.yorkcast.com/webcast/Play/89f7acb8d56e4de8827d1ade8efa42661d

Meeting Materials

Public Docket: In addition to providing input at the public meeting, stakeholders are invited to provide their perspectives on the discussion questions through the public docket.

Related Information: